Atrium Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNA and other ETFs, options, and stocks.About RNA
Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need.
RNA Key Statistics
Stock Snapshot
As of today, Atrium Therapeutics(RNA) shares are valued at $14.82. The company's market cap stands at 253.81M.
During the trading session on 2026-03-07, Atrium Therapeutics(RNA) shares reached a daily high of $15.79 and a low of $14.71. At a current price of $14.82, the stock is +0.8% higher than the low and still -6.1% under the high.
Trading activity shows a volume of 1.05M, compared to an average daily volume of 3.14M.
Over the past 52 weeks, Atrium Therapeutics(RNA) stock has traded between a high of $16.77 and a low of $13.06.
Over the past 52 weeks, Atrium Therapeutics(RNA) stock has traded between a high of $16.77 and a low of $13.06.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.